Good and bad IRF-1: Role in tumor suppression versus autoimmune disease

Leukemia Research

Volumn 33, Issue 10, 2009, Pages 1301-1302

  Liebermann, Dan A ^a   Hoffman, Barbara ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 1;

ACUTE GRANULOCYTIC LEUKEMIA; AUTOIMMUNE DISEASE; BONE MARROW CELL; CANCER INHIBITION; CANCER SURVIVAL; CELL DIFFERENTIATION; DISEASE ASSOCIATION; EDITORIAL; GENE EXPRESSION; GENE FUNCTION; HUMAN; INNATE IMMUNITY; MYELODYSPLASTIC SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; TRANSCRIPTION INITIATION;

AUTOIMMUNE DISEASES; GENE EXPRESSION REGULATION; GENETIC VARIATION; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERFERON-BETA; MYELODYSPLASTIC SYNDROMES; RNA, MESSENGER; SUPPRESSION, GENETIC; SURVIVAL RATE; SURVIVORS; TRANSCRIPTIONAL ACTIVATION;

EID: 67649382933     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.03.038     Document Type: Editorial

References (23)

1. Taniguchi T., Ogasawara K., Takaoka A., and Tanaka N. IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 19 (2001) 623-655
2. Abdollahi A., Lord K., Hoffman-Liebermann B., and Liebermann D. Interferon regulatory factor-1 is a myeloid differentiation primary response gene induced by IL6 and leukemia inhibitory factor: role in growth inhibition. Cell Growth Differ 2 (1991) 401-407
3. Maratheftis C.I., Giannouli S., Spachidou M.P., Panayotou G., and Voulgarelis M. RNA interference of interferon regulatory factor-1 gene expression in THP-1 cell line leads to Toll-like receptor-4 overexpression/activation as well as up-modulation of annexin-II. Neoplasia 9 December (12) (2007) 1012-1020
4. Colonna M. TLR pathways and IFN-regulatory factors: to each its own. Eur J Immunol 37 Febuary (2) (2007) 306-309
5. Vila-del Sol V., Punzón C., and Fresno M. IFN-gamma-induced TNF-alpha expression is regulated by interferon regulatory factors 1 and 8 in mouse macrophages. J Immunol 181 October (7) (2008) 4461-4470
6. Aly S., Mages J., Reiling N., Kalinke U., Decker T., Lang R., and Ehlers S. Mycobacteria-induced granuloma necrosis depends on IRF-1. J Cell Mol Med August (2008) [Epub ahead of print]
7. Schedel M., Pinto L.A., Schaub B., Rosenstiel P., Cherkasov D., Cameron L., Klopp N., Illig T., Vogelberg C., Weiland S.K., von Mutius E., Lohoff M., and Kabesch M. IRF-1 gene variations influence IgE regulation and atopy. Am J Respir Crit Care Med 177 March (6) (2008) 613-621 Epub 2007 Dec 13
8. Dror N., Alter-Koltunoff M., Azriel A., Amariglio N., Jacob-Hirsch J., Zeligson S., Morgenstern A., Tamura T., Hauser H., Rechavi G., Ozato K., and Levi B.Z. Identification of IRF-8 and IRF-1 target genes in activated macrophages. Mol Immunol 44 January (4) (2007) 338-346 Epub 2006 April 4
9. Liebermann D.A., and Hoffman B. Myeloid differentiation (MyD)/growth arrest DNA damage (GADD) genes in tumor suppression, immunity& inflammation. Leukemia 16 (2002) 527-541
10. Liebermann D.A., and Hoffman B. Myeloid differentiation (MyD) primary response genes in hematopoiesis. Blood Cells Mol Dis 31 2 (2003) 213-228
11. Willman C.L., Sever C.E., Palavicini M.G., Harada H., Tanaka N., Slovak M.L., Yamamoto H., Harada K., Meeker T.C., List A.F., and Taniguchi T. Deletion of IRF-1, mapping to chromosome 5q31.1, inhuman leukemia and preleukemic myelodysplasia. Science 259 (1993) 968-971
12. Green W.B., Slovak M.L., Chen I.M., Pallavicini M., Hecht J.L., and Willman C.L. Lack of IRF-1 expression in acute promyelocytic leukemia and in a subset of acute myeloid leukemias with del (5) (q31). Leukemia 13 12 (1999) 1960-1971
13. Harada H., Kondo T., Ogawa S., Tamura T., Kitagawa M., Tanaka N., Lamphier M.S., Hirai H., and Taniguchi T. Accel-eratedexonskipping of IRF-1 mRNA in human myelodysplasia/leukemia; apossible mechanism of tumor sup-pressorinactivation. Oncogene 9 (1994) 3313-3320
14. Mayeda A., Helfman D.M., and Krainer A.R. Modulation of exon-skipping and inclusion by heterogeneous nuclearribonucleoprotein A1 and pre-mRNAsplicing factor SF2/ASF. Mol Cell Biol 13 (1993) 2993-3001
15. Tzoanopoulos D., Speletas M., Arvanitidis K., Veiopoulou C., Kyriaki S., Thyphronitis G., Sideras P., Kartalis G., and Ritis K. Low expression of interferon regulatory factor-1 and identification of novel exons skipping in patients with chronic myeloid leukaemia. Br J Haematol 119 1 (2002) 46-53
16. Maratheftis C.I., Bolaraki P.E., Giannouli S., Kapsogeorgou E.K., Moutsopoulos H.M., and Voulgarelis M. Aberrant alternative splicing of interferon regulatory factor-1 (IRF-1) inmyelodysplastic hematopoietic progenitor cells. Leuk Res 30 (2006) 1177-1185
17. Zeimet A.G., Reimer D., Wolf D., Fiegl H., Concin N., Wiedemair A., Wolf A.M., Rumpold H., Müller-Holzner E., and Marth C. Intratumoral interferon regulatory factor (IRF)-1 but not IRF-2 is of relevance in predicting patient outcome in ovarian cancer. Int J Cancer December (2008 Dec 15) [Epub ahead of print]
18. Lowney J.K., Boucher L.D., Swanson P.E., and Doherty G.M. Interferon regulatory factor-1 and -2 expression in human melanoma specimens. Ann Surg Oncol 6 (1999) 604-608
19. Connett J.M., Badri L., Giordano T.J., Connett W.C., and Doherty G.M. Interferon regulatory factor 1 (IRF-1) and IRF-2 expression in breast cancer tissue microarrays. J Interferon Cytokine Res 25 (2005) 587-594
20. Lee E.J., Jo M., Park J., Zhang W., and Lee J.H. Alternative splicing variants of IRF-1 lacking exons 7, 8, and 9 in cervical cancer. Biochem Biophys Res Commun 347 September (4) (2006) 882-888 Epub 2006 July 5
21. Giannouli S., Tzoanopoulos D., Ritis K., Kartalis G., Moutsopoulos H.M., and Voulgarelis M. Autoimmune manifestations in human myelodysplasia: a positive correlation with interferonregulatory factor-1 (IRF-1) expression. Ann Rheum Dis 63 5 (2004) 578-582
22. Giannouli S., Voulgarelis M., Zintzaras E., Tzioufas A.G., and Moutsopoulos H.M. Autoimmunephenomena in myelodysplastic syndromes: a 4-yr prospective study. Rheumatology 43 5 (2004) 626-632
23. Pinheiro R.F., Metze K., Silva M.R.R., and Chauffaille M.L. The ambiguous role of Interferon Regulatory Factor-1 (IRF-1) immunoexpression in Myelodysplastic Syndrome. Leukemia Research 33 (2009) 1308-1312